The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants
- 7 February 2005
- journal article
- research article
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 35 (6), 609-617
- https://doi.org/10.1038/sj.bmt.1704861
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myelomaBlood, 2003
- High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple MyelomaThe New England Journal of Medicine, 2003
- Allogeneic hematopoietic cell transplantation for multiple myelomaSeminars in Hematology, 2001
- Increased conventional chemotherapy does not improve survival in multiple myeloma: long-term results of two PETHEMA trials including 914 patientsThe Hematology Journal, 2001
- Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.Journal of Clinical Oncology, 1998
- A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple MyelomaThe New England Journal of Medicine, 1996
- Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma.Journal of Clinical Oncology, 1995
- Allogeneic Bone Marrow Transplantation in Multiple MyelomaThe New England Journal of Medicine, 1991
- Bone Marrow Transplantation in Three Patients with Multiple MyelomaActa Medica Scandinavica, 1986
- Treatment for Multiple MyelomaJama-Journal Of The American Medical Association, 1969